Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | DNA | INCY | ||
| Company | Biomarin Pharmaceuticals | Ginkgo Bioworks Hldgs Inc | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 90.00 | 8.40 | 63.52 | ||
| High | 90.79 | 8.78 | 64.46 | ||
| Low | 89.37 | 8.05 | 63.05 | ||
| Last | 90.02 | 8.15 | 64.14 | ||
| Change | unch | -0.15 | +1.12 | ||
| % Change | unch | -1.81% | +1.78% | ||
| Volume | 1,262,400 | 1,379,000 | 1,566,700 | ||
| 20-Day Average Volume | 1,530,025 | 1,498,763 | 2,086,810 | ||
| Previous Close | 90.02 | 8.30 | 63.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 87.97 | 11.10 | 63.19 | ||
| 20-Day Raw Stochastic | 67.34% | 9.45% | 43.19% | ||
| 20-Day Relative Strength | 56.84% | 36.60% | 54.29% | ||
| Weighted Alpha | +0.14 | -93.06 | +6.12 | ||
| Today's Opinion | 72% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 56% Buy | 100% Sell | 72% Buy | ||
| Last Month's Opinion | 24% Sell | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.55% since 08/16/24 | -8.01% since 08/16/24 | +3.19% since 08/16/24 | ||
| Low | 89.37 on 08/23/24 | 7.29 on 08/20/24 | 62.06 on 08/19/24 | ||
| High | 94.85 on 08/20/24 | 9.40 on 08/19/24 | 64.90 on 08/21/24 | ||
| 1-Month | |||||
| %Chg | +6.62% since 07/23/24 | -32.35% since 07/23/24 | -2.52% since 07/23/24 | ||
| Low | 80.06 on 08/05/24 | 7.29 on 08/20/24 | 60.19 on 08/08/24 | ||
| High | 94.85 on 08/20/24 | 16.39 on 08/01/24 | 70.36 on 07/25/24 | ||
| 3-Month | |||||
| %Chg | +18.60% since 05/23/24 | -68.96% since 05/23/24 | +11.64% since 05/23/24 | ||
| Low | 73.68 on 05/30/24 | 7.29 on 08/20/24 | 56.41 on 05/29/24 | ||
| High | 94.85 on 08/20/24 | 27.16 on 05/28/24 | 70.36 on 07/25/24 | ||
| 6-Month | |||||
| %Chg | -1.34% since 02/23/24 | -84.56% since 02/23/24 | +5.86% since 02/23/24 | ||
| Low | 73.68 on 05/30/24 | 7.29 on 08/20/24 | 50.35 on 04/30/24 | ||
| High | 94.85 on 08/20/24 | 64.40 on 02/29/24 | 70.36 on 07/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,092,998 | 18,021,916 | 14,402,060 | ||
| Shares Outstanding, K | 189,880 | 2,211,278 | 224,541 | ||
| Annual Sales | 2,419,230,000 | 251,460,000 | 3,695,650,000 | ||
| Annual Net Income | 167,650,000 | -892,870,000 | 597,600,000 | ||
| Last Quarter Sales | 712,030,000 | 56,210,000 | 1,043,760,000 | ||
| Last Quarter Net Income | 107,170,000 | -217,180,000 | -444,600,000 | ||
| 60-Month Beta | 0.32 | 1.14 | 0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.96 on 08/05/24 | -3.20 on 08/08/24 | -1.82 on 07/30/24 | ||
| Latest Earnings Date | 08/05/24 | 08/08/24 | 07/30/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 50.57 | 0.00 | 787.75 | ||